![](https://www.diabetesnews.com/wp-content/uploads/2013/06/drug-prices1-150x150.jpg)
A new pooled analysis shows DPP-4 inhibitors have a greater safety and tolerability profile when compared to other antihyperglycemic agents.
Read more
A new pooled analysis shows DPP-4 inhibitors have a greater safety and tolerability profile when compared to other antihyperglycemic agents.
Read more